• Solid Biosciences will present seven research posters at the ESGCT congress in Hamburg, Germany, October 27-30, 2026.
• SGT-003 findings scheduled for October 28 describe restored muscle-protein complex stability and improved muscle integrity in Duchenne muscular dystrophy.
• October 29 presentations cover improved POLARIS-101 gene delivery, including successful delivery to multiple tissues following depletion of preexisting antibodies.
• Manufacturing research scheduled for October 28-29 focuses on increasing viral vector yields, improving quality and scaling production.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solid Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200800PRIMZONEFULLFEED9849184) on October 20, 2026, and is solely responsible for the information contained therein.